A teratologic suppressor role for p53 in benzo(a)pyrene–treated transgenic p53-deficient mice

Nature Genetics

Volumn 10, Issue 2, 1995, Pages 181-187

  Nicol, Christopher J ^a   Harrison, Maureen L ^a   Laposa, Rebecca R ^a   Gimelshtein, Inga L ^a   Wells, Peter G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA DAMAGE; DNA REPAIR; GENOTYPE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; TERATOGENICITY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ABNORMALITIES, DRUG-INDUCED; ANIMAL; BASE SEQUENCE; BENZO(A)PYRENE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; FEMALE; FETAL RESORPTION; GENE DELETION; GENES, P53; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PREGNANCY; PREGNANCY, ANIMAL; SUPPORT, NON-U.S. GOV'T; TETRACHLORODIBENZODIOXIN;

ANIMALIA; MUS MUSCULUS;

EID: 0029006469     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0695-181     Document Type: Article

References (45)

1. Manson, J. M. Developmental toxicity of alkylating agents: mechanism of action. In The Biochemical Basis of Chemical Teratogenesis. (ed Juchau, M. R.) 95-136 (Elsevier, New York, 1980).
2. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R. W. Participation of p53 protein in the cellular response to DMA damage. Cancer Res. 51, 6304-6311 (1991).
3. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature362, 847-849 (1993).
4. Clarke, A. R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852 (1993).
5. Merritt, A. J. et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54, 614-617 (1994).
6. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49-53 (1991).
7. Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238 (1990).
8. Srivastava, S., Zou, Z. Q., Pirollo, K., Blattner, W. & Chang, E. H. Germ line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348, 747-749 (1990).
9. Donehower, L. A. et al. Mice deficient for p53 are developmental normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
10. Harvey, M. et al. Spontaneous and carcinogen-induced tumorigenesis inp53-deficient mice. Nature Genet. 5, 225-229 (1993).
11. Fritsche, M., Haessler, C. & Brandner, G. Induction of nuclear accumulation of the tumour-suppressor protein p53 by DMA-damaging agents. Oncogene 8, 307-318 (1993).
12. Zhan, Q., Carrier, F. & Fornace, A. J., Induction of cellular p53 activity by DMA-damaging agents and growth arrest. Molec. cell. Biol. 13, 4242-4250 (1993).
13. Schmid, P., Lorenz, A., Hameister, H. & Montenarh, M. Expression of p53during mouse embryogenesis. Development 113, 857-865 (1991).
14. Louis, J. M., Mcfarland, V. W., May, P. & Mora, P. T. The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochim. biophys. Acta 950, 395-402 (1988).
15. Phillips, D. H. Fifty years of B[a]P. Nature 303, 468-472 (1983).
16. Shum, S., Jensen, N. M. & Nebert, D. W. The murine Ah locus: in utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. Teratology 20, 365-376 (1979).
17. Gelboin, H. V., tabolism, activation, and carcinogenesis: Role and regulation of mixed function oxidases and related enzymes. Physiol. Rev. 60, 1107-1166 (1980).
18. Mamett, L. J., Reed, G. A. & Dennison, D. J. Prostaglandinsynthasedependent activation of 7, 8-dihydro-7, 8-dihydroxybenzo[a]pyrene to mutagenic derivatives. Biochem. biophys. Res. Commun. 82, 210-216 (1978).
19. Wrighton, S. A. & Stevens, J. C. The human hepatic cytochromes P-450 involved in drug metabolism. Crit. Rev. Toxicol. 22, 1-21 (1992).
20. Okey, A. B., Riddick, D. S. & Harper, P. A. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends pharmacol. Sci. 15, 226-232 (1994).
21. Shen, E. S., Guengerich, F. P. & Olson, J. R. Biphasic response for hepatic microsomal enzyme induction by 2, 3, 7, 8-tetrachlorodibenzodioxin in C57BL/6J and DBA/2J mice. Biochem. Pharmcol. 38, 4075-4084 (1989).
22. Van den berg, M., De Jongh, J., Poiger, H. & Olson, J. R. The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit. Rev. Toxicol. 24, 1-74 (1994).
23. Birnbaum, L. S., Weber, H., Harris, M. W., Lamb, J. C. IV. & McKinney, J. D. Toxic interaction of specific polychlorinated biphenyls and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin: increased incidence of cleft palates in mice. Toxicol. appl. Pharmacol. 77, 292-302 (1985).
24. Burke, M. D. et al. Ethoxy-, pentoxy-and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34, 3337-3345 (1985).
25. Jones, K. L. & Smith, D. W. The fetal alcohol syndrome. Teratology 12, 1-10 (1975).
26. Hanson, J. W. & Smith, D. W. The fetal hydantoin syndrome. J. Pediatr. 87, 285-290 (1975).
27. Finnell, R. H. & Chernoff, G. F. Variable patterns of malformation in the mouse fetal hydantoin syndrome. Am. J. med. Genet. 19, 463-471 (1984).
28. Strickler, S. M. et al. Genetic predisposition to phenytoin induced birth defects. Lancet 2, 746-749 (1985).
29. Scolnik, D. et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazapine monotherapy. J. Am. med. Assoc. 271, 767-770 (1994).
30. Sands, A., Donehower, L. A. & Bradley, A. Gene-targeting and the p53 tumour-suppressor gene. Mutat. Res. 307, 557-572 (1994).
31. Jacks, T. et al. Tumor spectrum analysis in p53 mutant mice. Curr. Biol. 4, 1-7 (1994).
32. Purdie, C. A. et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603-609 (1994).
33. Sah, V. P. et al. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10, XXX-YYY (1995).
34. Winn, L. M. & Wells, P. G. Phenytoin-initiated DMA oxidation in murine embryo culture, and embryoprotection by the antioxidative enzymes superoxide dismutase and catalase: Evidence for reactive oxygen species-mediated DMA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol. Pharmacol. (in the press).
35. Liu, L. & Wells, P. G. DMA oxidation as a potential molecular mechanism mediating drug-induced birth defects: Phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2’-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues. Free Rad. Biol. Med. (in the press).
36. Kastan, M. B. et al. A mammalian cell cycle checkpoint pathway utilizingp53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).
37. Cleaver, J. E. It was a very good year for DMA repair. Cell 76, 1-4 (1994).
38. McWhir, J., Selfridge, J., Harrison, D. J., Squires, S. & Melton, D. W. Mice with DMA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nature Genet. 5, 217-223 (1993).
39. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295-300 (1992).
40. Manson, J. M. & Kang, Y. J. Test methods for assessing female reproductive and developmental toxicology. In Principles and Methods of Toxicology, (ed Hayes, A. W.), 3, 989-1037 (Raven Press, New York. 1994).
41. Smart, Y. C., Fraser, I. S., Roberts, T. K., Clancy, R. L. & Cripps, A. W. Fertilization and early pregnancy loss in heathy women attempting conception. Clin. Reproduct. Fertil. 1, 177-184 (1982).
42. Rolfe, B. E. Detection of fetal wastage. Fertil. Steril. 37, 655-660 (1982).
43. Roberts, C. J. & Lowe, C. R. Where have all the conceptions gone. Lancet1, 498-499 (1975).
44. Gupta, R. C. Nonrandom binding of the carcinogen N-hydroxy-2-acetyl aminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. natl. Acad. Sci. U. S. A. 81, 6943-6947 (1984).
45. Timme, T. L. & Thompson, C. Rapid allelotype analysis of p53 knockout mice. Benchmarks 17, 461-463 (1994).